PAI-1 and the metabolic syndrome: links, causes, and consequences.
about
A comprehensive review on metabolic syndromeCaloric Restriction as a Strategy to Improve Vascular Dysfunction in Metabolic DisordersSystematic Review of Metabolic Syndrome Biomarkers: A Panel for Early Detection, Management, and Risk Stratification in the West Virginian PopulationThe prothrombotic tendency in metabolic syndrome: focus on the potential mechanisms involved in impaired haemostasis and fibrinolytic balanceIncreased sensitivity of the circadian system to temporal changes in the feeding regime of spontaneously hypertensive rats - a potential role for Bmal2 in the liverA review of the mechanisms and effectiveness of dietary polyphenols in reducing oxidative stress and thrombotic riskSynergistic effects of hypofibrinolysis and genetic and acquired risk factors on the risk of a first venous thrombosisGenome-wide association study for circulating levels of PAI-1 provides novel insights into its regulationTGF-beta1-induced plasminogen activator inhibitor-1 expression in vascular smooth muscle cells requires pp60(c-src)/EGFR(Y845) and Rho/ROCK signaling.Characterization of human mesenchymal stem cell secretome at early steps of adipocyte and osteoblast differentiation.Detection and characterisation of microcirculatory abnormalities in the skin of diabetic patients with microvascular complications.A Phytochemical-rich Multivitamin-multimineral Supplement Is Bioavailable and Reduces Serum Oxidized Low-density Lipoprotein, Myeloperoxidase, and Plasminogen Activator Inhibitor-1 in a Four-week Pilot trial of Healthy Individuals.Metabolic syndrome and risk of venous thromboembolism: Longitudinal Investigation of Thromboembolism Etiology.Day/Night rhythm of hemostatic factors in obstructive sleep apnea.Breast cancer and metabolic syndrome linked through the plasminogen activator inhibitor-1 cycleNovel risk factors of cardiovascular disease and their associations between obesity, physical activity and physical fitnessIncreased low-grade inflammation and plasminogen-activator inhibitor-1 level in nondippers with sleep apnea syndrome.The Association of the Metabolic Syndrome with PAI-1 and t-PA LevelsMetabolically protective cytokines adiponectin and fibroblast growth factor-21 are increased by acute overfeeding in healthy humansPAI-1 antagonists: the promise and the peril.Metabolic factors, adipose tissue, and plasminogen activator inhibitor-1 levels in type 2 diabetes: findings from the look AHEAD studyImpaired leptomeningeal collateral flow contributes to the poor outcome following experimental stroke in the Type 2 diabetic mice.Implication of low level inflammation in the insulin resistance of adipose tissue at late pregnancyImpact of obesity on the risk of venous thromboembolism in an inpatient pediatric population.Adipokines (adiponectin and plasminogen activator inhhibitor-1) in metabolic syndrome.Association of dietary patterns with serum adipokines among Japanese: a cross-sectional study.Prevalence, components, and correlates of metabolic syndrome (MetS) among elderly MuscovitesAdiponectin: an adipokine with protective features against metabolic syndrome.Circulating levels of TNF-α are associated with impaired glucose tolerance, increased insulin resistance, and ethnicity: the Insulin Resistance Atherosclerosis StudyPlasminogen activator inhibitor-1 4G/5G polymorphism is associated with metabolic syndrome parameters in Malaysian subjects.Effect of plasminogen activator inhibitor-1 and tissue plasminogen activator polymorphisms on susceptibility to type 2 diabetes in Malaysian subjects.Plasminogen activator inhibitor-1 concentrations and bone mineral density in postmenopausal women with type 2 diabetes mellitus.Beneficial Effects of Sarpogrelate and Rosuvastatin in High Fat Diet/Streptozotocin-Induced Nephropathy in Mice.Association among Fibrinolytic Proteins, Metabolic Syndrome Components, Insulin Secretion, and Resistance in Schoolchildren.Impact of Nutrition on Cerebral Circulation and Cognition in the Metabolic Syndrome.Drug discovery in the metabolic syndrome: context and some recent developments.Fatty acid-induced production of plasminogen activator inhibitor-1 by adipose macrophages is greater in middle-aged versus younger adult participants.Resveratrol suppresses PAI-1 gene expression in a human in vitro model of inflamed adipose tissue.Insulin resistance and inflammation markers in myocardial infarctionThe association between metabolic syndrome and vascular endothelial dysfunction in adolescents.
P2860
Q21284500-B2FD49C9-CF7B-467E-973D-2608B1949373Q26744463-C49282E7-6AA7-453F-B357-3593E74AF989Q26774109-00238A86-101E-484C-92EA-4B8EF14EDDA5Q27003277-ABEEFDFB-1A63-4F6C-BD39-0CDF0427C273Q27305171-87FAE656-18FC-42C3-B005-F1D9CBC6B20EQ28301541-B4FCA8D8-B308-47C7-A041-D0D8B21F33FBQ28754730-8FAE11A0-4342-4EAA-B153-90FAF7C32BB8Q30415902-FB95C07D-D362-44B2-8D4C-7E6733D59615Q30440157-B4BAF2F8-F130-4FC6-B1F2-8FE3A6F05AABQ33321325-CB9A7B72-F0DD-4152-B729-7B807AF99655Q33327392-06A1F515-5C26-4523-9591-6CD462BC5CCBQ33570079-B00E4E31-709C-4A72-BE38-8316B28DEE5EQ33605003-90C2FE88-5359-4AFE-9549-29CCB8A94489Q33700780-4F776DF1-34CC-45D5-BDD7-8EE15D773BDAQ33715393-616C8154-FD42-4C29-9511-C7C7E11D89C7Q34074016-447A12A6-C0BE-4676-BCD3-50411F1CEEC2Q34734265-423D9879-944D-4C24-AE3D-9E501F5B5397Q34929646-E00AE331-BED9-49D8-95E7-B4DA7EAB1171Q35036783-87B44326-69F1-40F6-B6D6-C3C02D3E15E5Q35048985-F4A75B68-13D7-4AA4-9BF2-7258606BA2B8Q35088730-3FC3FFE8-EAF2-4F5F-BBD3-79947A06904FQ35142897-C056946E-44CC-4A4B-A716-1A9C5A2EA422Q35417015-02083D9A-C262-411C-BB23-35EF8228CECEQ35541853-98D1AF69-BE3A-45FC-AE0A-2D4E57604AA5Q35686289-1A07A629-AE7A-467E-8638-7EB5D45F8E62Q35746965-C6EBED45-EF5D-419C-B83D-C33B46A2AB13Q35748660-ECC52698-98E8-4E58-ADCA-F7F5F0036949Q35763433-66B3C32E-B792-4787-A4E1-832C45A3F360Q35869657-0EFE759D-7F87-4268-AB43-7FE62AC11543Q35906917-CCBC8375-E158-4DB0-972D-FE25F60D1AB9Q35911869-183FB1E6-2C33-4D12-ABED-D357FDB5BAD3Q35945451-9FEFE86E-E926-4724-A486-B47F81EEB2B4Q35994934-B8694FAB-4B74-4059-B963-92550BA35EA4Q36304590-FF0C1918-64B6-446E-A339-887AE5B3D9ECQ36329909-14ABD3E4-217F-46C1-A239-D336287429F2Q36822448-C53C4E3D-A317-4C08-9DD8-990904542993Q36895081-4DD428B6-464F-412A-8F8F-B374C46052A4Q36933430-BE582031-1FE9-4AF1-B781-A0193D4A5CD9Q36975794-BA24F5DA-BFCF-46DE-9452-02D5D8C5ED46Q36986439-58287592-F1B4-4B1A-B9C8-600F50961743
P2860
PAI-1 and the metabolic syndrome: links, causes, and consequences.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
PAI-1 and the metabolic syndrome: links, causes, and consequences.
@ast
PAI-1 and the metabolic syndrome: links, causes, and consequences.
@en
type
label
PAI-1 and the metabolic syndrome: links, causes, and consequences.
@ast
PAI-1 and the metabolic syndrome: links, causes, and consequences.
@en
prefLabel
PAI-1 and the metabolic syndrome: links, causes, and consequences.
@ast
PAI-1 and the metabolic syndrome: links, causes, and consequences.
@en
P1476
PAI-1 and the metabolic syndrome: links, causes, and consequences.
@en
P2093
Irène Juhan-Vague
Marie-Christine Alessi
P304
P356
10.1161/01.ATV.0000242905.41404.68
P407
P577
2006-08-24T00:00:00Z